Tenders Are Invited For Dk 021: 2015-33690000-3 Medicines Different (Nc 024: 2023 47352 Sodiumuretic Protein Type B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Set, Immunofluorescent Analysis; B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Control Material), Nc 024: 2023 53717 Ivd Phospholipids (In Vitro Diagnosis), Control Material; Nk 024: 2023 53707 Pancretic Secretory Inhibitor Of Trypsin Ivd (Diagnosis In Vitro), Set, Enzyme -Linked Immunosorbent Analysis).
Tenders Are Invited For Dk 021: 2015-33690000-3 Medicines Different (Nc 024: 2023 47352 Sodiumuretic Protein Type B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Set, Immunofluorescent Analysis; B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Control Material), Nc 024: 2023 53717 Ivd Phospholipids (In Vitro Diagnosis), Control Material; Nk 024: 2023 53707 Pancretic Secretory Inhibitor Of Trypsin Ivd (Diagnosis In Vitro), Set, Enzyme -Linked Immunosorbent Analysis).
Dk 021: 2015-33690000-3 Medicines Different (Nc 024: 2023 47352 Sodiumuretic Protein Type B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Set, Immunofluorescent Analysis; B/N-Terminal Sodiumuretic Peptide Pro B-Type Ivd (In Vitro Diagnosis), Control Material), Nc 024: 2023 53717 Ivd Phospholipids (In Vitro Diagnosis), Control Material; Nk 024: 2023 53707 Pancretic Secretory Inhibitor Of Trypsin Ivd (Diagnosis In Vitro), Set, Enzyme -Linked Immunosorbent Analysis).
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
